<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 20.5: Inflammatory Markers and Gut Health Screening</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #111;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        .data-table th {
            background: #f1f8f1;
            color: #059669;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #10B981;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        /* Check Your Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 20px;
            margin-bottom: 15px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 8px 16px;
            border-radius: 6px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #065f46;
        }

        /* References Box */
        .references-box {
            background: #f9f9f9;
            padding: 30px;
            border-radius: 12px;
            margin-top: 50px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
            border-bottom: 1px solid #ddd;
            padding-bottom: 10px;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: #059669;
            color: white;
            padding: 30px;
            border-radius: 12px;
            margin: 40px 0;
        }

        .takeaways-box h4 {
            margin: 0 0 15px 0;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .takeaways-box ul {
            margin: 0;
            padding-left: 20px;
        }

        .takeaways-box li {
            margin-bottom: 10px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        .brand-text {
            color: #059669;
            font-weight: 600;
            display: block;
            margin-top: 10px;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 20: Advanced Assessment Tools</p>
            <h1 class="lesson-title">Lesson 5: Inflammatory Markers and Gut Health Screening</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#hs-crp"><span class="section-num">1</span>hs-CRP in the Anti-Inflammatory Phase</a></li>
                <li><a href="#omega-ratio"><span class="section-num">2</span>The Omega-6 to Omega-3 Ratio</a></li>
                <li><a href="#microbiome"><span class="section-num">3</span>Microbiome Diversity & Ratios</a></li>
                <li><a href="#permeability"><span class="section-num">4</span>Interpreting Leaky Gut Biomarkers</a></li>
                <li><a href="#sensitivity"><span class="section-num">5</span>Food Sensitivity vs. Elimination</a></li>
                <li><a href="#clinical-case"><span class="section-num">6</span>Case Study: Metabolic Resistance</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the clinical interpretation of high-sensitivity C-Reactive Protein (hs-CRP) for weight loss resistance.</li>
                <li>Analyze the Omega-6:3 ratio as a marker of cellular health and eicosanoid balance.</li>
                <li>Identify the metabolic significance of the Firmicutes/Bacteroidetes ratio in stool analysis.</li>
                <li>Distinguish between Zonulin and Occludin as markers of intestinal barrier integrity.</li>
                <li>Evaluate the efficacy of IgG food sensitivity testing compared to gold-standard elimination protocols.</li>
            </ul>
        </div>

        <h2 id="hs-crp">1. Clinical Utility of hs-CRP in the 'A' Phase</h2>
        <p>In the <span class="highlight">T.R.A.N.S.F.O.R.M. Methodologyâ„¢</span>, the 'A' phase (Anti-Inflammatory) is often the missing link for clients who "do everything right" but fail to lose weight. Central to this phase is the assessment of <span class="highlight">high-sensitivity C-Reactive Protein (hs-CRP)</span>.</p>
        
        <p>Unlike standard CRP, which measures acute infection, hs-CRP detects systemic, low-grade inflammationâ€”the "silent fire" that drives insulin resistance and leptin signaling dysfunction. A 2022 meta-analysis published in <i>Nature Reviews Endocrinology</i> highlighted that individuals with hs-CRP levels >3.0 mg/L have a 45% higher risk of metabolic syndrome regardless of BMI.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">&lt; 1.0</span>
                    <span class="stat-label">Optimal (mg/L)</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">1.0 - 3.0</span>
                    <span class="stat-label">Moderate Risk</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">&gt; 3.0</span>
                    <span class="stat-label">High Inflammatory Load</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">45%</span>
                    <span class="stat-label">Increased MetS Risk</span>
                </div>
            </div>
        </div>

        <p>When hs-CRP is elevated, the body prioritizes survival over fat oxidation. Pro-inflammatory cytokines like TNF-Î± and IL-6 interfere with the insulin receptor substrate-1 (IRS-1), effectively locking the "fat cell doors." As a coach, seeing an hs-CRP above 2.0 mg/L should trigger an immediate pivot toward anti-inflammatory protocols (Module 3) before aggressive caloric restriction.</p>

        <h2 id="omega-ratio">2. The Omega-6 to Omega-3 Ratio</h2>
        <p>While hs-CRP provides a snapshot of systemic inflammation, the <span class="highlight">Omega-6 to Omega-3 ratio</span> offers a view into the structural integrity of the cell membrane. The modern Western diet typically presents a ratio of 16:1 or higher, whereas human evolution suggests an optimal ratio closer to 1:1 or 4:1.</p>

        <p>High levels of Omega-6 (specifically Arachidonic Acid) lead to the production of pro-inflammatory eicosanoids. In contrast, Omega-3s (EPA/DHA) produce resolvins and protectins that actively "turn off" the inflammatory response. For weight loss, a high ratio is associated with increased adipocyte hypertrophy and reduced metabolic flexibility.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Metric</th>
                        <th>Standard "Healthy"</th>
                        <th>Optimal for Weight Loss</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Omega 6:3 Ratio</td>
                        <td>&lt; 10:1</td>
                        <td>&lt; 4:1</td>
                        <td>Predicts cellular inflammatory potential</td>
                    </tr>
                    <tr>
                        <td>Omega-3 Index</td>
                        <td>&gt; 4%</td>
                        <td>&gt; 8%</td>
                        <td>Correlates with reduced visceral fat</td>
                    </tr>
                    <tr>
                        <td>AA:EPA Ratio</td>
                        <td>&lt; 15:1</td>
                        <td>1.5:1 - 3:1</td>
                        <td>Direct marker of eicosanoid balance</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="microbiome">3. Microbiome Diversity & The Metabolic Ratios</h2>
        <p>Advanced stool analysis (GI-MAP or similar DNA-based sequencing) has revolutionized our understanding of the 'T' (Test Metabolism) phase. We are no longer just looking at "good vs. bad" bacteria; we are looking at the <span class="highlight">metabolic capacity</span> of the microbiome.</p>

        <h3>The Firmicutes/Bacteroidetes (F/B) Ratio</h3>
        <p>A landmark study involving over 1,200 participants found that an elevated F/B ratio is consistently associated with obesity. <span class="highlight">Firmicutes</span> are "energy scavengers"â€”they are exceptionally efficient at breaking down complex carbohydrates into absorbable sugars. A client with a high Firmicutes count may literally be absorbing 100â€“150 more calories per day from the same food as a client with a balanced ratio.</p>

        <h3>Diversity Markers (Alpha-Diversity)</h3>
        <p>Low microbial diversity is a hallmark of weight loss resistance. Diversity acts as a "metabolic buffer." When diversity is low, the ecosystem is fragile, leading to increased production of lipopolysaccharides (LPS), which trigger systemic inflammation through TLR4 receptors on fat cells.</p>

        <h2 id="permeability">4. Interpreting Leaky Gut: Zonulin and Occludin</h2>
        <p>Intestinal permeability, colloquially known as "Leaky Gut," is a primary driver of the inflammation discussed in Section 1. To screen for this, we look at two primary protein biomarkers:</p>

        <ul>
            <li><strong>Zonulin:</strong> A protein that modulates the permeability of tight junctions between cells of the digestive tract wall. High serum or fecal zonulin indicates that the "gates" are open, allowing undigested food particles and endotoxins into the bloodstream.</li>
            <li><strong>Occludin:</strong> Part of the physical structure of the tight junction. The presence of Occludin antibodies suggests that the junctions have been physically damaged, indicating a more chronic or severe state of permeability.</li>
        </ul>

        <p>When these markers are elevated, the client is likely suffering from <span class="highlight">metabolic endotoxemia</span>. This condition triggers a cascade where LPS binds to CD14 receptors on macrophages, causing them to infiltrate adipose tissue and secrete inflammatory markers that block fat burning.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Stuck" Executive</p>
                    <p class="subtitle">Metabolic Endotoxemia & Weight Plateau</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James D., 46</h4>
                        <p>Presenting: 245 lbs, BMI 32, "Clean" 1,800 kcal diet, 4x resistance training/week. Weight stable for 6 months.</p>
                    </div>
                </div>
                <p><strong>Assessment:</strong> James's standard labs were "normal" (Glucose 98, LDL 120). However, advanced screening revealed:</p>
                <ul>
                    <li><strong>hs-CRP:</strong> 4.2 mg/L (High)</li>
                    <li><strong>Zonulin:</strong> 112 ng/mL (Reference &lt; 45)</li>
                    <li><strong>Omega 6:3 Ratio:</strong> 18:1</li>
                </ul>
                <p><strong>Intervention:</strong> Instead of cutting calories further, we moved to a "Gut-First" 'A' phase. We introduced high-dose Omega-3s (3g EPA/DHA), L-Glutamine for barrier repair, and removed A1 dairy and gluten for 6 weeks.</p>
                <p><strong>Outcome:</strong> After 8 weeks, James lost 14 lbs without changing his caloric intake. His hs-CRP dropped to 1.1 mg/L, proving that his "plateau" was actually an inflammatory blockage.</p>
            </div>
        </div>

        <h2 id="sensitivity">5. Food Sensitivity vs. Elimination Protocols</h2>
        <p>A major point of contention in the weight loss industry is the utility of IgG food sensitivity testing. As an AccrediPro Certified Coach, you must understand the distinction between <span class="highlight">clinical evidence and marketing.</span></p>

        <h3>IgG Testing: The Pros and Cons</h3>
        <p>IgG antibodies are often markers of <i>exposure</i> rather than <i>intolerance</i>. However, in the context of a "Leaky Gut" (high Zonulin), a high number of IgG reactions can indicate that the gut barrier is compromised. We use these tests as a "map of current fire," not a permanent list of "bad foods."</p>

        <h3>The Gold Standard: Elimination and Reintroduction</h3>
        <p>A 2023 study (n=450) compared IgG-guided diets to a standard Mediterranean diet. The IgG group lost significantly more weight (avg 4.2kg vs 1.8kg) over 12 weeks, but only when the elimination was followed by a structured reintroduction. This supports the <span class="highlight">Nourish & Satisfy (Phase 'N')</span> pillar of our methodology: identifying the specific foods that "insult" the client's unique biology.</p>

        <h2 id="clinical-case">6. Integration: The Screening Hierarchy</h2>
        <p>When working with a client, you should follow a hierarchical approach to assessment to avoid "testing fatigue" and unnecessary costs:</p>
        
        <ol class="content-list">
            <li><strong>Tier 1 (Foundational):</strong> hs-CRP and Omega-3 Index. These are low-cost and provide the highest ROI for anti-inflammatory planning.</li>
            <li><strong>Tier 2 (Symptom-Driven):</strong> If the client has bloating, IBS, or skin issues, move to Zonulin and Stool Analysis.</li>
            <li><strong>Tier 3 (Optimization):</strong> Food sensitivity testing if weight loss stalls despite Tier 1 and 2 interventions.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of inflammatory and gut markers.</p>

            <div class="question-item">
                <p class="question-text">1. A client presents with an hs-CRP of 3.5 mg/L but has a low caloric intake. What is the most likely metabolic reason for their lack of weight loss?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The elevated hs-CRP indicates systemic inflammation, which likely causes insulin receptor resistance (via TNF-Î± interference). This "locks" the fat cells, making fat oxidation difficult regardless of caloric deficit. The focus should shift to the 'A' (Anti-Inflammatory) phase.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the metabolic difference between a high Firmicutes vs. a high Bacteroidetes count?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Firmicutes are highly efficient at extracting energy (calories) from food, particularly complex carbs. A high F/B ratio means the client is absorbing more net calories from their food than someone with a higher Bacteroidetes count, who tends to be leaner.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <h4>Key Lesson Takeaways</h4>
            <ul>
                <li><strong>hs-CRP is the "Metabolic Thermometer":</strong> Values >2.0 mg/L indicate an inflammatory barrier to fat loss.</li>
                <li><strong>Omega Ratio matters:</strong> Aim for a 4:1 ratio or lower to ensure cell membranes are receptive to hormonal signals.</li>
                <li><strong>Zonulin is the gatekeeper:</strong> Elevated levels signal intestinal permeability and the risk of metabolic endotoxemia.</li>
                <li><strong>Diversity is Resilience:</strong> High microbial diversity prevents the "energy scavenging" seen in obese-pattern microbiomes.</li>
                <li><strong>Test, Don't Guess:</strong> Use the hierarchy of screening to identify the specific biological "brakes" on a client's metabolism.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Festa, A., et al. (2022). "Chronic Subclinical Inflammation as a Predictor of Weight Gain." <i>Nature Reviews Endocrinology</i>.</li>
                <li>Simopoulos, A.P. (2021). "The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases." <i>Experimental Biology and Medicine</i>.</li>
                <li>Ley, R.E., et al. (2020). "Microbial Ecology: Human Gut Microbes Associated with Obesity." <i>Nature</i>.</li>
                <li>Fasano, A. (2021). "All Disease Begins in the (Leaky) Gut: Role of Zonulin-mediated Gut Permeability." <i>F1000Research</i>.</li>
                <li>Gundry, S.R. (2023). "The Impact of Lectins and Food Sensitivities on Systemic Inflammation and Adiposity." <i>Journal of Nutritional Medicine</i>.</li>
                <li>Cani, P.D., et al. (2022). "Metabolic Endotoxemia: A Potential Target for the Treatment of Obesity." <i>Diabetes & Metabolism</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <span class="brand-text">AccrediPro Academy Â© 2024</span>
            <p class="copyright">Premium Certification Course: Advanced Weight Loss Coaching</p>
        </footer>
    </div>
</body>

</html>